High Amylose Resistant Starch Diet Ameliorates Oxidative Stress, Inflammation, and Progression of Chronic Kidney Disease

Abstract

Inflammation is a major mediator of CKD progression and is partly driven by altered gut microbiome and intestinal barrier disruption, events which are caused by: urea influx in the intestine resulting in dominance of urease-possessing bacteria; disruption of epithelial barrier by urea-derived ammonia leading to endotoxemia and bacterial translocation; and restriction of potassium-rich fruits and vegetables which are common sources of fermentable fiber. Restriction of these foods leads to depletion of bacteria that convert indigestible carbohydrates to short chain fatty acids which are important nutrients for colonocytes and regulatory T lymphocytes. We hypothesized that a high resistant starch diet attenuates CKD progression. Male Sprague Dawley rats were fed a chow containing 0.7% adenine for 2 weeks to induce CKD. Rats were then fed diets supplemented with amylopectin (low-fiber control) or high fermentable fiber (amylose maize resistant starch, HAM-RS2) for 3 weeks. CKD rats consuming low fiber diet exhibited reduced creatinine clearance, interstitial fibrosis, inflammation, tubular damage, activation of NFkB, upregulation of pro-inflammatory, pro-oxidant, and pro-fibrotic molecules; impaired Nrf2 activity, down-regulation of antioxidant enzymes, and disruption of colonic epithelial tight junction. The high resistant starch diet significantly attenuated these abnormalities. Thus high resistant starch diet retards CKD progression and attenuates oxidative stress and inflammation in rats. Future studies are needed to explore the impact of HAM-RS2 in CKD patients.

References 37

1. 1.

   Vaziri ND (2012 ) CKD impairs barrier function and alters microbial flora of the intestine - A major link to inflammation and uremic toxicity. Current Opinion in Nephrology & Hypertension 21:587–92.

   Not in our library10.1097/mnh.0b013e328358c8d5

2. 2.

   Vaziri ND, Yuan J, Rahimi A, Ni Z, Said H, et al (2012 ) Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation. Nephrol Dial Transplant 27:2686–2693.

   Not in our library10.1093/ndt/gfr624

3. 3.

   Vaziri ND, Yuan J, Nazertehrani S, Ni Z, Liu S (2013 ) Chronic kidney disease causes disruption of gastric and small intestinal epithelial tight junction. Amer J Nephrol 38:99–103.

   Not in our library10.1159/000353764

4. 4.

   Vaziri ND, Wong J, Pahl MV, Piceno YM, Yuan J, et al. (2013) Chronic kidney disease alters the composition of intestinal microbial flora. Kidney Int 83: 308–15 2013.

   Not in our library10.1038/ki.2012.345

5. 5.

   Wong J, Piceno YM, DeSantis TZ, Pahl M, Andersen GL, et al (2014 ) Expansion of urease and uricase-containing indole- and p-cresol-forming and contraction of short chain fatty acid-producing intestinal bacteria in ESRD. American Journal Nephrol 39:230–237.

   Not in our library10.1159/000360010

6. 6.

   Vaziri ND, Goshtasby N, Yuan J, Jellbauer S, Moradi H, et al (2012 ) Uremic human plasma degrades intestinal epithelial barrier structure and function. Am J Nephrology 36:438–443.

   Not in our library10.1159/000343886

7. 7.

   Vaziri ND, Yuan J, Norris K (2012 ) Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in CKD. Am J Nephrology 37:1–6.

   Not in our library10.1159/000345969

8. 8.

   Bossola M, Sanguinetti M, Scribano D (2009 ) Circulating bacterial-derived DNA fragments and markers of inflammation in chronic hemodialysis patients. Clin J Am Soc Nephrol 4:379–385.

   Not in our library10.2215/cjn.03490708

9. 9.

   Wang F, Jiang H, Shi K (2012 ) Gut bacterial translocation is associated with micro-inflammation in end-stage renal disease patients. Nephrology (Carlton) 17:733–738.

   Not in our library10.1111/j.1440-1797.2012.01647.x

10. 10.

    Wang F, Zhang P, Jiang H, Cheng S (2012 ) Gut bacterial translocation contributes to micro inflammation in experimental uremia. Dig Dis Sci 57:2856–2862.

    Not in our library10.1007/s10620-012-2242-0

11. 11.

    Shi K, Wang F, Jiang H, Liu H, Wei M, et al. (2014) Gut bacterial translocation may aggravate microinflammation in hemodialysis patients. Digestive Diseases and Sciences [in press].

    Not in our library10.1007/s10620-014-3202-7

12. 12.

    Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, et al (2013 ) The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341:569–573.

    Not in our library10.1126/science.1241165

13. 13.

    Vaziri ND, Pahl MV, Crum A, Norris K (2012 ) Effect of uremia on structure and function of immune system. J Ren Nutr 22:149–156.

    Not in our library10.1053/j.jrn.2011.10.020

14. 14.

    Hendrikx TK, van Gurp EA, Mol WM, Schoordijk W, Sewgobind VD, et al (2009 ) End-stage renal failure and regulatory activities of CD4+CD25bright+FoxP3+ T-cells. Nephrol Dial Transplant 24:1969–1978.

    Not in our library10.1093/ndt/gfp005

15. 15.

    Vaziri ND, Ni Z, Oveisi F, Liang K, Pandian R (2002 ) Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension 39:135–141.

    Not in our library10.1161/hy0102.100540

16. 16.

    Sakurai H, Hisada Y, Ueno M, Sugiura M, Kawashima K, et al (1996 ) Activation of transcription factor NF-kappa B in experimental glomerulonephritis in rats. Biochim Biophys Acta 1316:132–138.

    Not in our library10.1016/0925-4439(96)00022-1

17. 17.

    Kim HJ, Vaziri ND (2010 ) Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Am J Physiol Renal Physiol 298:662–671.

    Not in our library10.1152/ajprenal.00421.2009

18. 18.

    Aminzadeh MA, Sato T, Vaziri ND (2012 ) Participation of endoplasmic reticulum stress in the pathogenesis of spontaneous glomerulosclerosis-Role of intra-renal angiotensin system. Transl Res 160:309–318.

    Not in our library10.1016/j.trsl.2012.03.003

19. 19.

    Vaziri ND, Ni Z, Oveisi F, Liang K (2002 ) Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension 39:135–141.

    Not in our library10.1161/hy0102.100540

20. 20.

    Keenan MJ, Martin RJ, Raggio AM, McCutcheon KL, Brown IL, et al. (2012). High-amylose resistant starch increases hormones and improves structure and function of the gastrointestinal tract: a microarray study. J Nutrigenet Nutrigenomics. 5: p.26–44.

    Not in our library10.1159/000335319

21. 21.

    Keenan MJ, Zhou J, McCutcheon KL, Raggio AM, Bateman GH, et al (2006 ) Effects of resistant starch, a non-digestible fermentable fiber, on reducing body fat. Obesity 14:1523–1534.

    Not in our library10.1038/oby.2006.176

22. 22.

    Charrier JA, Martin RJ, McCutcheon KL, Raggio AM, Goldsmith F, et al (2013 ) High fat diet partially attenuates fermentation responses in rats fed resistant starch from high-amylose maize. Obesity 21:2350–2355.

    Not in our library10.1002/oby.20362

23. 23.

    Tachon S, Zhou J, Keenan M, Martin R, Marco M (2013 ) The intestinal microbiota in aged mice is modulated by dietary resistant starch and correlated to improvements in host responses FEMS Microbiology Ecology. 83:299–309.

    Not in our library10.1111/j.1574-6941.2012.01475.x

24. 24.

    Smith EA, Macfarlane GT (1996 ) Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. J Appl Bacteriol 81:288–302.

    Not in our library10.1111/j.1365-2672.1996.tb04331.x

25. 25.

    Smith EA, Macfarlane GT (1997 ) Formation of phenolic and indolic compounds by anaerobic bacteria in the human large intestine. Microb Ecol 33:180–188.

    Not in our library10.1007/s002489900020

26. 26.

    Tachon S, Zhou J, Keenan M, Martin R, Marco ML (2013). The intestinal microbiota in aged mice is modulated by dietary resistant starch and correlated with improvements in host responses. FEMS Microbiol Ecol,. 83(2): p.299–309.

    Not in our library10.1111/j.1574-6941.2012.01475.x

27. 27.

    Shen L, Keenan MJ, Raggio A, Williams C, Martin RJ (2011), Dietary-resistant starch improves maternal glycemic control in Goto-Kakazaki rat. Molecular Nutrition and Food Research,. 55: p. DOI426 10.1002/mnfr.201000605.

    Not in our library10.1002/mnfr.201000605

28. 28.

    Vidrine K, Ye J, Martin RJ, McCutcheon KL, Raggio AM, et al (2014 ) Resistant starch from high amylose maize (HAM-RS2) and dietary butyrate reduce abdominal fat by a different apparent mechanism. Obesity (Silver Spring). Feb 22(2):344–8.

    Not in our library10.1002/oby.20501

29. 29.

    Baer DJ, Stote KS, Henderson T, Paul DR, Okuma K, et al (2014 ) The metabolizable energy of dietary resistant maltodextrin is variable and alters fecal microbiota composition in adult men. J Nutr. 2014 Jul 144(7):1023–9.

    Not in our library10.3945/jn.113.185298

30. 30.

    Murtagh FE, Addington-Hall J, Higginson IJ (2007 ) The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis 14:82–99.

    Not in our library10.1053/j.ackd.2006.10.001

31. 31.

    Wutzke KD, Scholübbers D (2013 ) The metabolic effect of resistant starch and yoghurt on the renal and faecal nitrogen and ammonia excretion in humans as measured by lactose-[(15)N2] ureide. Isotopes Environ Health Stud 49:464–470.

    Not in our library10.1080/10256016.2013.804519

32. 32.

    Younes H, Alphonse JC, Behr SR, Demigné C (1999 ) Role of fermentable carbohydrate supplements with a low-protein diet in the course of chronic renal failure: experimental bases. Am J Kidney Dis 33:633–646.

    Not in our library10.1016/s0272-6386(99)70213-1

33. 33.

    Kalmokoff M, Zwicker B, O’Hara M, Matias F, Green J, et al (2013 ) Temporal change in the gut community of rats fed high amylose cornstarch is driven by endogenous urea rather than strictly on carbohydrate availability. Journal of applied microbiology. 114:1516–1528.

    Not in our library10.1111/jam.12157

34. 34.

    Zhou J, Hegsted M, McCutcheon KL, Keenan MJ, Xi X, et al (2006 ) Peptide YY and pro-glucagon mRNA expression patterns and regulation in the gut. Obesity (Silver Spring)14:683–689.

    Not in our library10.1038/oby.2006.77

35. 35.

    Zhou J, Martin RJ, Tulley RT, Raggio AM, McCutcheon KL, et al (2008 ) Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am J Physiol Endocrinol Metab 295:1160–1166.

    Not in our library10.1152/ajpendo.90637.2008

36. 36.

    Fujita H, Morii T, Fujishima H, Sato T, Shimizu T, et al (2014 ) The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential. Kidney Int 85:579–589.

    Not in our library10.1038/ki.2013.427

37. 37.

    Birt DF, Boylston T, Hendrich S, Jane JL, Hollis J, et al (2013 ) Resistant starch: promise for improving human health. Adv Nutr 6:587–601.

    Not in our library10.3945/an.113.004325

Cited by papers we hold 10

• Oxidative stress gene expression, DNA methylation, and gut microbiota interaction trigger Crohn’s disease: a multi-omics Mendelian randomization study · 2023
  No notice
• Intestinal Microbiota-Derived Short Chain Fatty Acids in Host Health and Disease · 2022
  No notice
• The Effects of Nutrition on the Gastrointestinal Microbiome of Cats and Dogs: Impact on Health and Disease · 2020
  No notice
• Dietary Components That May Influence the Disturbed Gut Microbiota in Chronic Kidney Disease · 2019
  No notice
• Inflammation in Renal Diseases: New and Old Players · 2019
  No notice
• The Signaling of Cellular Senescence in Diabetic Nephropathy · 2019
  No notice
• Microbiome–metabolome reveals the contribution of gut–kidney axis on kidney disease · 2019
  No notice
• Altered gut microbiota and microbial biomarkers associated with chronic kidney disease · 2018
  No notice
• An integrated lipidomics and metabolomics reveal nephroprotective effect and biochemical mechanism of Rheum officinale in chronic renal failure · 2016
  No notice
• Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis · 2015
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.